1 completed, 1 terminated, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Optic Nerve Neoplasms: new trials by email Literature Review of Optic Nerve Neoplasms trials Research Report on Optic Nerve Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma Temozolomide, ANP Therapy - Optic Nerve Glioma | Phase 3 | Withdrawn | Burzynski Research Institute | 2011-12-01 | 2017-07-26 | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer cyproheptadine hydrochloride, placebo - Cancer | Phase 3 | Terminated | University of South Florida | 22 | 2010-06-01 | 2015-07-02 |
| Combination Chemotherapy in Treating Children With Progressive Brain Tumors carboplatin, lomustine, procarbazine hydrochloride - Brain Tumors, Central Nervous System Tumors | Phase 3 | Completed | Children's Oncology Group | 428 | 1997-04-01 | 2013-09-09 |
Optic Nerve Glioma (3) · Astrocytoma (2) · Body Weight Changes (1) · Bone Neoplasms (1) · Brain Neoplasms (1) · Cachexia (1) · Central Nervous System Neoplasms (1) · Chondrosarcoma (1) · Choroid Plexus Neoplasms (1) · Familial ependymoma (1) · Fibrosarcoma (1) · Glioblastoma (1) · Hemangiosarcoma (1) · Hepatoblastoma (1) · Liposarcoma (1)
Cranial Nerve Diseases (3) · Cranial Nerve Neoplasms (3) · Eye Diseases (3) · Glioma (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Neuroectodermal Tumors (3) · Optic Nerve Diseases (3) · Peripheral Nervous System Neoplasms (3)
Carboplatin (1) · Cyproheptadine (1) · Lomustine (1) · Procarbazine (1) · Temozolomide (1) · Thioguanine (1) · Vincristine (1) · antineoplaston A10 (1) · antineoplaston AS 2-1 (1)
Burzynski Research Institute (1) · Children's Oncology Group (1) · University of South Florida (1)
United States (2) · Australia (1) · Canada (1) · Netherlands (1) · New Zealand (1) · Switzerland (1)
Jeffrey P. Krischer, PhD (1) · Joann Ater, MD (1) · Stanislaw R Burzynski, MD, PhD (1)
U10CA081920 (1)